Understanding Peptide Purity: What 99%+ Actually Means

"99% pure" is one of the most common claims on a research peptide product page, and one of the least understood. The number itself comes from a real analytical process — but knowing what it measures, and what it doesn't, matters a lot if you're relying on it for research design.

What "purity" is actually measuring

In the context of a research peptide, purity almost always refers to chemical purity, as determined by High-Performance Liquid Chromatography (HPLC) — not biological potency, not identity confirmation, and not sterility. Those are separate measurements, sometimes bundled into the same Certificate of Analysis, sometimes not.

How HPLC purity testing works

HPLC separates the components of a sample based on how they interact with a stationary phase (typically packed inside a column) versus a mobile solvent phase moving through it. Different molecules travel through the column at different rates depending on their size, charge, and hydrophobicity, and elute (exit the column) at different times.

As each component exits, a detector — usually measuring UV absorbance — records a peak. The area under each peak is proportional to the amount of that component in the sample. Purity by HPLC is calculated as the area of the target peptide's peak divided by the total area of all peaks in the chromatogram, expressed as a percentage.

A peptide reported at "99%+ purity" means that, by this area-under-the-curve method, roughly 99% or more of the detected material corresponds to a single peak identified as the target compound. The remaining ~1% or less represents impurities — typically truncated sequences, deletion or insertion errors from synthesis, deamidated variants, or residual solvents.

Why mass spectrometry matters too

HPLC alone tells you how much of your sample is one single, clean-eluting compound — but it doesn't confirm what that compound actually is. That's the role of mass spectrometry (MS), which measures the mass-to-charge ratio of ionized molecules and can confirm that the dominant peak in your HPLC trace has the molecular weight expected for your target sequence.

A rigorous Certificate of Analysis pairs both: HPLC for purity, and MS for identity confirmation. A high purity percentage attached to the wrong molecular weight is not a good outcome — and unfortunately, without MS data, that scenario is invisible.

What purity doesn't tell you

• It doesn't confirm biological activity. A peptide can be chemically pure and structurally correct while still folding incorrectly or losing activity, particularly for peptides with disulfide bonds or specific secondary structures.
• It doesn't confirm sterility. Endotoxin testing and microbial testing are separate assays, relevant mainly for research applications sensitive to contamination.
• It doesn't account for degradation after testing. A CoA reflects the sample's purity at the time of testing — how it's stored and handled afterward determines whether that purity holds.

Reading a Certificate of Analysis

A useful CoA generally includes:

1. The HPLC purity percentage, ideally with the actual chromatogram, not just the number.
2. Mass spec data confirming molecular weight against the expected sequence.
3. Batch or lot number, tying the certificate to a specific production run.
4. Testing date, so you can assess how much time has passed since verification.

If a supplier can't produce the underlying chromatogram and mass spec trace — just a number on a page — that's worth treating with more skepticism than a number backed by raw data.

Purity percentage and identity confirmation are two different questions. A rigorous CoA answers both.